Thrombopoietin level in patients with chronic liver diseases

Thrombopoietin level in patients with chronic liver diseases

Thrombocytopenia and oxidative stress are the most frequent problems in patients with chronic liver diseases as viral cirrhosis and schistosomiasis. So, this study aimed to evaluate the role of thrombopoietin (TPO) on the occurrence of thrombocytopenia and in differentiation between these diseases....

Full description

Bibliographic Details
Main Authors:	Laila A. Eissa, Lamees S. Gad, Ahmed M. Rabie, Amal M. El-Gayar
Format:	Article
Language:	English
Published:	Elsevier 2008-07-01
Series:	Annals of Hepatology
Subjects:	Cirrhosis hepatitis C virus schistosomiasis thrombopoietin oxidative stress lipid peroxidation
Online Access:	http://www.sciencedirect.com/science/article/pii/S166526811931854X

Similar Items

Study of thrombopoietin levels in some Egyptian patients with chronic liver diseases secondary to the hepatitis C virus
by: Enayat O. Ezzat, et al.
Published: (2012-01-01)

Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels
by: Afifi Ola, et al.
Published: (2007-01-01)

Correlations of folic acid, vitamin B12, homocysteine, and thrombopoietin to platelet count in HCV infection
by: Somayh S. Eissa, et al.
Published: (2012-01-01)

The pathophysiology of thrombocytopenia in chronic liver disease
by: Mitchell O, et al.
Published: (2016-04-01)

Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?
by: Sven R. Olson, et al.
Published: (2019-08-01)

Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies
by: Fabrizio Vianello, et al.
Published: (2014-03-01)

The thrombopoietin receptor: revisiting the master regulator of platelet production
by: Ian S. Hitchcock, et al.
Published: (2021-08-01)

The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis
by: Ingrid Lindquist, et al.
Published: (2022-01-01)

Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy
by: Yen-Chun Chen, et al.
Published: (2021-01-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Trombinol, a bioactive fraction of Psidium guajava, stimulates thrombopoietin expression in HepG2 cells
by: Guntur Berlian, et al.
Published: (2017-05-01)

Plasma thrombopoietin levels as additional tool in clinical management of thrombocytopenic neonates
by: Leendert Porcelijn, et al.
Published: (2020-01-01)

A novel peptide thrombopoietin mimetic designing and optimization using computational approach
by: Vimal kishor Singh, et al.
Published: (2016-08-01)

Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espfrito Santo
by: Patricia Lofego Goncalves, et al.
Published: (2013-01-01)

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study
by: Hiroaki Nomoto, et al.
Published: (2020-12-01)

Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019-01-01)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
by: Jerry L. Spivak, et al.
Published: (2021-03-01)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
by: Mengying Zhang, et al.
Published: (2023-09-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2018-01-01)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023-03-01)

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
by: Longfei Gao, et al.
Published: (2021-08-01)

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)

Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma
by: Yukihiro Nishikawa, et al.
Published: (2022-01-01)

A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
by: Gurleen Oberoi, et al.
Published: (2022-01-01)

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
by: V V PTUSHKIN, et al.
Published: (2018-07-01)

Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study
by: Yu Liu, et al.
Published: (2020-09-01)

Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy
by: Amr Shaaban Hanafy, et al.
Published: (2019-05-01)

Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity
by: Abhay Singh, et al.
Published: (2015-01-01)

GPIbα is the driving force of hepatic thrombopoietin generation
by: Danielle Karakas, et al.
Published: (2021-05-01)

Thrombopoietin participates in platelet activation in COVID-19 patients
by: Enrico Lupia, et al.
Published: (2022-11-01)

Perspectives of vitamin C upregulating regulatory T cells in the era of thrombopoietin receptor agonists for immune thrombocytopenia
by: Shiu Ying Tsao
Published: (2022-12-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers
by: Jean-Philippe Defour, et al.
Published: (2023-06-01)

Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study
by: Pei-Yuan Su, et al.
Published: (2021-11-01)

Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
by: Ondine Walter, et al.
Published: (2022-11-01)

Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
by: Isabelle Plo, et al.
Published: (2017-09-01)

A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation
by: Yu-Qian Sun, et al.
Published: (2019-11-01)

Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma
by: Barbara Vizio, et al.
Published: (2021-02-01)

Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study
by: Kodjo-Kunale Abassa, et al.
Published: (2022-03-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)